Examkin

Soru

Zorluk: ZorNeoplastic Processes

A 71-year-old woman with a 50-pack-year smoking history is referred to the oncology clinic after a routine chest radiograph reveals a 3.2-cm spiculated mass in the right upper lobe and a widened right paratracheal stripe. She has a chronic cough but is otherwise asymptomatic. Her performance status is excellent. Arrange the following steps in the most appropriate, evidence-based sequence for the diagnostic workup, clinical staging, and treatment planning of this patient's condition.

  1. 1Perform a contrast-enhanced computed tomography (CT) of the chest to anatomically characterize the mass and assess local extension.
  2. 2Obtain an 18F-FDG positron emission tomography (PET) scan to screen for distant metastases and identify metabolically active lymph nodes.
  3. 3Perform endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) to establish a tissue diagnosis and pathologically stage the mediastinum.
  4. 4Review the integrated clinical and pathological staging data at a multidisciplinary tumor board to evaluate surgical candidacy.
  5. 5Initiate definitive, stage-directed management, such as anatomical lung resection or definitive chemoradiotherapy.

Cevap

The correct sequence for the evaluation and management of suspected non-small cell lung cancer is: CT chest for anatomical characterization, followed by a PET scan for metabolic staging, then EBUS-TBNA for tissue diagnosis and pathological nodal staging, followed by multidisciplinary review to determine surgical candidacy, and finally the initiation of stage-directed therapy.
The correct sequence for the evaluation and management of suspected non-small cell lung cancer ensures accurate staging while minimizing unnecessary procedures. Anatomical imaging (CT) characterizes the initial finding. Metabolic imaging (PET) provides whole-body clinical staging and guides the subsequent biopsy. Invasive tissue sampling (EBUS-TBNA) pathologically confirms the diagnosis and precise nodal status. A multidisciplinary tumor board then synthesizes this data to recommend the optimal stage-directed therapy, which is subsequently executed.

Adım Adım Çözüm

1
Identify the need for advanced anatomical imaging.
Contrast-enhanced CT of the chest is selected to characterize the radiographic abnormality.
Plain radiographs lack the resolution to accurately determine the characteristics and local invasion of lung masses, making CT the requisite next step.
2
Determine the appropriate modality for whole-body clinical staging.
18F-FDG PET scan is utilized to assess for occult metastases and nodal avidity.
Before invasive biopsies, a PET scan maps out the most metabolically active sites to target for tissue sampling and ensures the patient does not have distant metastases.
3
Select the optimal method for obtaining a tissue diagnosis and confirming nodal stage.
EBUS-TBNA is performed to sample the primary tumor and suspicious paratracheal lymph nodes.
Tissue confirmation is mandatory because PET avidity alone cannot definitively diagnose malignancy or nodal involvement due to potential false positives from infection or inflammation.
4
Synthesize the gathered clinical and pathological data.
The case is reviewed at a multidisciplinary tumor board.
Complex oncologic decisions require input from medical oncology, radiation oncology, thoracic surgery, and pathology to formulate an optimal, consensus-driven treatment plan.
5
Execute the formulated treatment plan.
Stage-directed therapy is initiated.
Definitive management relies on accurate prior staging to ensure the intervention provides the best chance of survival and local control.

Anahtar Kavram

The diagnostic algorithm for suspected lung cancer systematically progresses from noninvasive anatomical imaging (CT), to metabolic clinical staging (PET), to targeted invasive tissue sampling (EBUS-TBNA), ensuring accurate pathological staging prior to definitive multidisciplinary treatment decisions.
Bu soruyu puanla

Konular

Neoplastic Processes

Bu konudan daha fazla soru